1. Home
  2. HTOO vs TLPH Comparison

HTOO vs TLPH Comparison

Compare HTOO & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTOO
  • TLPH
  • Stock Information
  • Founded
  • HTOO 2020
  • TLPH 2005
  • Country
  • HTOO Ireland
  • TLPH United States
  • Employees
  • HTOO N/A
  • TLPH N/A
  • Industry
  • HTOO Natural Gas Distribution
  • TLPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTOO Utilities
  • TLPH Health Care
  • Exchange
  • HTOO Nasdaq
  • TLPH Nasdaq
  • Market Cap
  • HTOO 12.3M
  • TLPH 12.7M
  • IPO Year
  • HTOO N/A
  • TLPH 2011
  • Fundamental
  • Price
  • HTOO $0.49
  • TLPH $0.61
  • Analyst Decision
  • HTOO Strong Buy
  • TLPH Strong Buy
  • Analyst Count
  • HTOO 1
  • TLPH 2
  • Target Price
  • HTOO $3.50
  • TLPH $4.50
  • AVG Volume (30 Days)
  • HTOO 16.4M
  • TLPH 93.3K
  • Earning Date
  • HTOO 12-24-2024
  • TLPH 11-13-2024
  • Dividend Yield
  • HTOO N/A
  • TLPH N/A
  • EPS Growth
  • HTOO N/A
  • TLPH N/A
  • EPS
  • HTOO N/A
  • TLPH N/A
  • Revenue
  • HTOO $4,580,524.00
  • TLPH $281,000.00
  • Revenue This Year
  • HTOO $329.95
  • TLPH N/A
  • Revenue Next Year
  • HTOO $344.33
  • TLPH N/A
  • P/E Ratio
  • HTOO N/A
  • TLPH N/A
  • Revenue Growth
  • HTOO N/A
  • TLPH N/A
  • 52 Week Low
  • HTOO $0.28
  • TLPH $0.61
  • 52 Week High
  • HTOO $4.65
  • TLPH $1.61
  • Technical
  • Relative Strength Index (RSI)
  • HTOO 51.31
  • TLPH 37.58
  • Support Level
  • HTOO $0.42
  • TLPH $0.61
  • Resistance Level
  • HTOO $0.59
  • TLPH $0.76
  • Average True Range (ATR)
  • HTOO 0.11
  • TLPH 0.06
  • MACD
  • HTOO 0.01
  • TLPH -0.00
  • Stochastic Oscillator
  • HTOO 42.65
  • TLPH 10.53

About HTOO Fusion Fuel Green PLC

Fusion Fuel Green PLC is a company that has developed a Green Hydrogen production technology. It is focused on generating cost-effective and competitively priced Green Hydrogen.

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Share on Social Networks: